• Users Online: 262
  • Print this page
  • Email this page
This article has been cited by
1Mirtazapine for the treatment of psychosis in Parkinsonís disease: Any silver linings?
Abhishek Lenka
Annals of Movement Disorders.2020;3(1)69
[DOI]
2Pharmacological management of Parkinsonís disease in older people
Nadia Mouchaileh,Andrew J. Hughes
Journal of Pharmacy Practice and Research.2020;50(5)445
[DOI]
3Pimavanserin and Parkinsonís Disease Psychosis: A Narrative Review
Jamir Pitton Rissardo,Õcaro Durante,Idan Sharon,Ana LetŪcia Fornari Caprara
Brain Sciences.2022;12(10)1286
[DOI]
4A Pragmatic Approach to the Perioperative Management of Parkinsonís Disease
Abhishek Lenka,Shivam Om Mittal,Guillaume Lamotte,Fernando Luis Pagan
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.2021;48(3)299
[DOI]
5Management of psychiatric disorders in patients with parkinson's diseases
Adarsh Tripathi,PawanKumar Gupta,Teena Bansal
Indian Journal of Psychiatry.2022;64(8)330
[DOI]
6Practical pearls to improve the efficacy and tolerability of levodopa in Parkinsonís disease
Abhishek Lenka,Gianluca Di Maria,Guillaume Lamotte,Laxman Bahroo,Joseph Jankovic
Expert Review of Neurotherapeutics.2022;22(6)489
[DOI]
7The role of mirtazapine in the management of psychosis in Parkinsonís disease
NA Uvais
Annals of Movement Disorders.2020;3(1)67
[DOI]